The board of directors at Kallyope has a wealth of experience in the scientific and pharmaceutical industries, as well as a variety of educational backgrounds. This experience and knowledge helps to guide the company in its research and development of new treatments and therapies.
Amy Schulman
Director
Charles Zuker
Founder
David Anderson
Scientific Advisor
Jeffrey Friedman
Scientific Advisor
Josh Wolfe
Strategic Advisor
Michael Brown
Scientific Advisor
Nancy Thornberry
Chair, R&D
Peter Hecht
Director
Richard Axel
Founder
Richard Scheller
Scientific Advisor
Terry McGuire
Director
Tim Kutzkey
Director
Tom Maniatis
Founder
Tony Evnin
Director
William Rieflin
Director
View all